Principal changes in the scope of consolidation in 2022 (Tables)

12 Months Ended

Dec. 31, 2022

The final purchase price allocation led to the recognition of €609 million of goodwill, determined as follows:


(€ million)			Fair value at acquisition date
Other intangible assets			493


Other current and non-current assets and liabilities			(13)
Cash and cash equivalents			118
Deferred taxes, net			(81)
Net assets of Amunix			517
Goodwill			609
Purchase price			1,126

The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of €2,118 million:


(€ million)			Fair value at acquisition date
Other intangible assets			396
Deferred tax liabilities			(93)
Other current and non-current assets and liabilities			235
Cash and cash equivalents			247
Shire contingent consideration liability (see Note D.18.)			(323)

Net assets of Translate Bio			462
Goodwill			2,118
Purchase price			2,580

The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of €912 million:


(€ million)			Fair value at acquisition date
Other intangible assets			2,534


Other current and non-current assets and liabilities			(38)
Cash and cash equivalents			186
Net deferred tax position			(436)
Net assets of Principia			2,246
Goodwill			912
Purchase price			3,158

The final purchase price allocation, as presented in the table below, led to the recognition of goodwill of €930 million:


(€ million)			Fair value at acquisition date
Other intangible assets			1,549
Other current and non-current assets and liabilities			36
Net deferred tax position			(269)
Net assets of Synthorx			1,316
Goodwill			930
Purchase price			2,246